Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41598-017-08436-6.

Title:
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports
Description:
Pancreatic cancer is a lethal disease with poor prognosis. Gemcitabine has been the first line systemic treatment for pancreatic cancer. However, the rapid development of drug resistance has been a major hurdle in gemcitabine therapy leading to unsatisfactory patient outcomes. With the recent renewed understanding of glutamine metabolism involvement in drug resistance and immuno-response, we investigated the anti-tumor effect of a glutamine analog (6-diazo-5-oxo-L-norleucine) as an adjuvant treatment to sensitize chemoresistant pancreatic cancer cells. We demonstrate that disruption of glutamine metabolic pathways improves the efficacy of gemcitabine treatment. Such a disruption induces a cascade of events which impacts glycan biosynthesis through Hexosamine Biosynthesis Pathway (HBP), as well as cellular redox homeostasis, resulting in global changes in protein glycosylation, expression and functional effects. The proteome alterations induced in the resistant cancer cells and the secreted exosomes are intricately associated with the reduction in cell proliferation and the enhancement of cancer cell chemosensitivity. Proteins associated with EGFR signaling, including downstream AKT-mTOR pathways, MAPK pathway, as well as redox enzymes were downregulated in response to disruption of glutamine metabolic pathways.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,194,993 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$531,700 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $354,480 to $974,820.

Keywords {🔍}

cells, cancer, don, treatment, pubmed, article, pancreatic, cell, google, scholar, gemr, glutamine, proteins, protein, miapaca, cas, glycosylation, signaling, hours, fig, treated, pathways, analysis, egfr, proliferation, ros, resistance, untreated, data, cellular, exosomes, gem, drug, disruption, exosome, central, gemcitabine, pathway, including, nature, metabolic, redox, metabolism, expression, tumor, showed, glycan, bead, proteomics, biosynthesis,

Topics {✒️}

nature portfolio scientific instrument services activating hab18g/cd147-egfr-pstat3 signaling privacy policy phospho-stat3 kits advertising nature 496 nature 316 nature chemical tools software solutions reprints author information authors ubiquitin-mediated proteasomal degradation drug-resistant human adenocarcinoma pancreatic ductal adenocarcinoma sensitize chemo-resistant pdac 6-diazo-5-oxo-l-norleucine alexa568 goat anti-rabbit stable-isotope dimethyl labeling disrupting n-linked glycosylation original author serum-free media atop gemcitabine-metal–organic frameworks n-linked glycosylation sites serine/threonine-protein kinases provide udp-n-acetylglucosamine receptor tyrosine kinases phospho-p44/p42 mapk vivo drug-induced apoptosis 100 mg/ml fibronectin overnight tandem mass spectrometry thermo fisher scientific mass spectrometry analysis permissions smad3/cmyc axis key gemcitabine-metabolising enzyme potential anti-cancer activity kras-regulated metabolic pathway hexosamine biosynthetic pathway chemoresistant pancreatic cancer full size image trans-proteomic pipeline egfr-related signaling pathways suppress udp-glcnac generation phospho-s6 ribosomal protein site-specific glycosylation occupancy mass spectrometric data proteomics data analysis pancreatic cancer survival

Questions {❓}

  • ER stress and hexosamine pathway during tumourigenesis: A pas de deux?
  • Reactive oxygen species and cancer paradox: To promote or to suppress?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
         description:Pancreatic cancer is a lethal disease with poor prognosis. Gemcitabine has been the first line systemic treatment for pancreatic cancer. However, the rapid development of drug resistance has been a major hurdle in gemcitabine therapy leading to unsatisfactory patient outcomes. With the recent renewed understanding of glutamine metabolism involvement in drug resistance and immuno-response, we investigated the anti-tumor effect of a glutamine analog (6-diazo-5-oxo-L-norleucine) as an adjuvant treatment to sensitize chemoresistant pancreatic cancer cells. We demonstrate that disruption of glutamine metabolic pathways improves the efficacy of gemcitabine treatment. Such a disruption induces a cascade of events which impacts glycan biosynthesis through Hexosamine Biosynthesis Pathway (HBP), as well as cellular redox homeostasis, resulting in global changes in protein glycosylation, expression and functional effects. The proteome alterations induced in the resistant cancer cells and the secreted exosomes are intricately associated with the reduction in cell proliferation and the enhancement of cancer cell chemosensitivity. Proteins associated with EGFR signaling, including downstream AKT-mTOR pathways, MAPK pathway, as well as redox enzymes were downregulated in response to disruption of glutamine metabolic pathways.
         datePublished:2017-08-11T00:00:00Z
         dateModified:2017-08-11T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41598-017-08436-6
         keywords:
            Cancer metabolism
            Cancer therapeutic resistance
            Mass spectrometry
            Pancreatic cancer
            Proteomics
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig7_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig8_HTML.jpg
         isPartOf:
            name:Scientific Reports
            issn:
               2045-2322
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ru Chen
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Lisa A Lai
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yumi Sullivan
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Melissa Wong
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lei Wang
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jonah Riddell
               affiliation:
                     name:Cell Signaling Technology, Inc
                     address:
                        name:Cell Signaling Technology, Inc, Danvers, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Linda Jung
               affiliation:
                     name:Cell Signaling Technology, Inc
                     address:
                        name:Cell Signaling Technology, Inc, Danvers, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Venu G. Pillarisetty
               url:http://orcid.org/0000-0002-1162-9643
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Surgery, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teresa A. Brentnall
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sheng Pan
               affiliation:
                     name:University of Washington
                     address:
                        name:Department of Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
      description:Pancreatic cancer is a lethal disease with poor prognosis. Gemcitabine has been the first line systemic treatment for pancreatic cancer. However, the rapid development of drug resistance has been a major hurdle in gemcitabine therapy leading to unsatisfactory patient outcomes. With the recent renewed understanding of glutamine metabolism involvement in drug resistance and immuno-response, we investigated the anti-tumor effect of a glutamine analog (6-diazo-5-oxo-L-norleucine) as an adjuvant treatment to sensitize chemoresistant pancreatic cancer cells. We demonstrate that disruption of glutamine metabolic pathways improves the efficacy of gemcitabine treatment. Such a disruption induces a cascade of events which impacts glycan biosynthesis through Hexosamine Biosynthesis Pathway (HBP), as well as cellular redox homeostasis, resulting in global changes in protein glycosylation, expression and functional effects. The proteome alterations induced in the resistant cancer cells and the secreted exosomes are intricately associated with the reduction in cell proliferation and the enhancement of cancer cell chemosensitivity. Proteins associated with EGFR signaling, including downstream AKT-mTOR pathways, MAPK pathway, as well as redox enzymes were downregulated in response to disruption of glutamine metabolic pathways.
      datePublished:2017-08-11T00:00:00Z
      dateModified:2017-08-11T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41598-017-08436-6
      keywords:
         Cancer metabolism
         Cancer therapeutic resistance
         Mass spectrometry
         Pancreatic cancer
         Proteomics
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig7_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig8_HTML.jpg
      isPartOf:
         name:Scientific Reports
         issn:
            2045-2322
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ru Chen
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Lisa A Lai
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yumi Sullivan
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Melissa Wong
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lei Wang
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jonah Riddell
            affiliation:
                  name:Cell Signaling Technology, Inc
                  address:
                     name:Cell Signaling Technology, Inc, Danvers, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Linda Jung
            affiliation:
                  name:Cell Signaling Technology, Inc
                  address:
                     name:Cell Signaling Technology, Inc, Danvers, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Venu G. Pillarisetty
            url:http://orcid.org/0000-0002-1162-9643
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Surgery, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teresa A. Brentnall
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sheng Pan
            affiliation:
                  name:University of Washington
                  address:
                     name:Department of Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Scientific Reports
      issn:
         2045-2322
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:Cell Signaling Technology, Inc
      address:
         name:Cell Signaling Technology, Inc, Danvers, USA
         type:PostalAddress
      name:Cell Signaling Technology, Inc
      address:
         name:Cell Signaling Technology, Inc, Danvers, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Surgery, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Department of Medicine, University of Washington, Seattle, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ru Chen
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Lisa A Lai
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Yumi Sullivan
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Melissa Wong
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Lei Wang
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Jonah Riddell
      affiliation:
            name:Cell Signaling Technology, Inc
            address:
               name:Cell Signaling Technology, Inc, Danvers, USA
               type:PostalAddress
            type:Organization
      name:Linda Jung
      affiliation:
            name:Cell Signaling Technology, Inc
            address:
               name:Cell Signaling Technology, Inc, Danvers, USA
               type:PostalAddress
            type:Organization
      name:Venu G. Pillarisetty
      url:http://orcid.org/0000-0002-1162-9643
      affiliation:
            name:University of Washington
            address:
               name:Department of Surgery, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Teresa A. Brentnall
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Sheng Pan
      affiliation:
            name:University of Washington
            address:
               name:Department of Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Cell Signaling Technology, Inc, Danvers, USA
      name:Cell Signaling Technology, Inc, Danvers, USA
      name:Department of Surgery, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA
      name:Department of Medicine, University of Washington, Seattle, USA

External Links {🔗}(212)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

5.18s.